Lacosamide as useful for epilepsy in kids as in adults

New evidence continues to demonstrate the efficacy and tolerability of lacosamide in children and adolescents with focal seizures. An international trial of more than 300 patients aged 4 to 17 years from over 100 sites has shown the drug reduces focal seizure frequency compared to placebo. The patients all had a confirmed diagnosis of epilepsy ...

Already a member?

Login to keep reading.

© 2022 the limbic